BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 30085200)

  • 1. A validated proton beam therapy patch-field protocol for effective treatment of large hepatocellular carcinoma.
    Nakamura M; Fukumitsu N; Kamizawa S; Numajiri H; Nemoto Murofushi K; Ohnishi K; Aihara T; Ishikawa H; Okumura T; Tsuboi K; Sakurai H
    J Radiat Res; 2018 Sep; 59(5):632-638. PubMed ID: 30085200
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Designed-seamless irradiation technique for extended whole mediastinal proton-beam irradiation for esophageal cancer.
    Okonogi N; Hashimoto T; Ishida M; Ohno T; Terunuma T; Okumura T; Sakae T; Sakurai H
    Radiat Oncol; 2012 Oct; 7():173. PubMed ID: 23078998
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between pretreatment retention rate of indocyanine green 15 min after administration and life prognosis in patients with HCC treated by proton beam therapy.
    Mizumoto M; Oshiro Y; Okumura T; Fukuda K; Fukumitsu N; Abei M; Ishikawa H; Ohnishi K; Numajiri H; Tsuboi K; Sakurai H
    Radiother Oncol; 2014 Oct; 113(1):54-9. PubMed ID: 25248924
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proton-beam therapy for hepatocellular carcinoma associated with portal vein tumor thrombosis.
    Sugahara S; Nakayama H; Fukuda K; Mizumoto M; Tokita M; Abei M; Shoda J; Matsuzaki Y; Thono E; Tsuboi K; Tokuuye K
    Strahlenther Onkol; 2009 Dec; 185(12):782-8. PubMed ID: 20013087
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proton beam therapy for hepatocellular carcinoma patients with severe cirrhosis.
    Hata M; Tokuuye K; Sugahara S; Fukumitsu N; Hashimoto T; Ohnishi K; Nemoto K; Ohara K; Matsuzaki Y; Akine Y
    Strahlenther Onkol; 2006 Dec; 182(12):713-20. PubMed ID: 17149578
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proton beam therapy outcomes for localized unresectable hepatocellular carcinoma.
    Chadha AS; Gunther JR; Hsieh CE; Aliru M; Mahadevan LS; Venkatesulu BP; Crane CH; Das P; Herman JM; Koay EJ; Taniguchi C; Holliday EB; Minsky BD; Suh Y; Park P; Sawakuchi G; Beddar S; Odisio BC; Gupta S; Loyer E; Kaur H; Raghav K; Javle MM; Kaseb AO; Krishnan S
    Radiother Oncol; 2019 Apr; 133():54-61. PubMed ID: 30935582
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proton beam therapy for hepatocellular carcinoma associated with inferior vena cava tumor thrombus.
    Sekino Y; Okumura T; Fukumitsu N; Iizumi T; Numajiri H; Mizumoto M; Nakai K; Nonaka T; Ishikawa H; Sakurai H
    J Cancer Res Clin Oncol; 2020 Mar; 146(3):711-720. PubMed ID: 31776663
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Dose distributions of proton beam therapy for hepatocellular carcinoma: a comparative study of treatment planning with 3D-conformal radiation therapy or intensity-modulated radiation therapy].
    Li JM; Yu JM; Liu SW; Chen Q; Mu XK; Jiang QA; Zhao MH; Zhang JG
    Zhonghua Yi Xue Za Zhi; 2009 Dec; 89(45):3201-6. PubMed ID: 20193534
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proton therapy for hepatocellular carcinoma: Current knowledges and future perspectives.
    Yoo GS; Yu JI; Park HC
    World J Gastroenterol; 2018 Jul; 24(28):3090-3100. PubMed ID: 30065555
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Repeated proton beam therapy for hepatocellular carcinoma.
    Hashimoto T; Tokuuye K; Fukumitsu N; Igaki H; Hata M; Kagei K; Sugahara S; Ohara K; Matsuzaki Y; Akine Y
    Int J Radiat Oncol Biol Phys; 2006 May; 65(1):196-202. PubMed ID: 16563656
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Internal target volume definition using four-dimensional CT and dosimetric evaluation for hepatocellular carcinoma].
    Xi M; Liu MZ; Deng XW; Liu H; Huang XY; Zhang L; Li QQ; Hu YH; Cai L; Cui NJ
    Ai Zheng; 2007 Jan; 26(1):1-8. PubMed ID: 17222359
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Phase 2 Study of Image-Guided Proton Therapy for Operable or Ablation-Treatable Primary Hepatocellular Carcinoma.
    Iwata H; Ogino H; Hattori Y; Nakajima K; Nomura K; Hashimoto S; Hayashi K; Toshito T; Sasaki S; Mizoe JE; Shibamoto Y
    Int J Radiat Oncol Biol Phys; 2021 Sep; 111(1):117-126. PubMed ID: 33798564
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proton beam therapy for large hepatocellular carcinoma.
    Sugahara S; Oshiro Y; Nakayama H; Fukuda K; Mizumoto M; Abei M; Shoda J; Matsuzaki Y; Thono E; Tokita M; Tsuboi K; Tokuuye K
    Int J Radiat Oncol Biol Phys; 2010 Feb; 76(2):460-6. PubMed ID: 19427743
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Two-week schedule of hypofractionated radiotherapy as a local salvage treatment for small hepatocellular carcinoma.
    Park JH; Yoon SM; Lim YS; Kim SY; Shim JH; Kim KM; Lee HC; Cho B; Park G; Kim JH
    J Gastroenterol Hepatol; 2013 Oct; 28(10):1638-42. PubMed ID: 23621519
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term clinical outcomes of patients receiving proton beam therapy for caudate lobe hepatocellular carcinoma.
    Iizumi T; Okumura T; Sekino Y; Takahashi H; Tsai YL; Takizawa D; Ishida T; Hiroshima Y; Nakamura M; Shimizu S; Saito T; Numajiri H; Mizumoto M; Nakai K; Sakurai H
    J Radiat Res; 2021 Jul; 62(4):682-687. PubMed ID: 34036362
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictors of Radiation-Induced Liver Disease in Eastern and Western Patients With Hepatocellular Carcinoma Undergoing Proton Beam Therapy.
    Hsieh CE; Venkatesulu BP; Lee CH; Hung SP; Wong PF; Aithala SP; Kim BK; Rao A; Tung-Chieh Chang J; Tsang NM; Wang CC; Lee CC; Lin CC; Tseng JH; Chou WC; Wang YC; Krishnan S; Hong JH
    Int J Radiat Oncol Biol Phys; 2019 Sep; 105(1):73-86. PubMed ID: 30797890
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk-adapted simultaneous integrated boost-proton beam therapy (SIB-PBT) for advanced hepatocellular carcinoma with tumour vascular thrombosis.
    Kim DY; Park JW; Kim TH; Kim BH; Moon SH; Kim SS; Woo SM; Koh YH; Lee WJ; Kim CM
    Radiother Oncol; 2017 Jan; 122(1):122-129. PubMed ID: 28034460
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of tumor thrombus location on the outcome of external-beam radiation therapy in advanced hepatocellular carcinoma with macrovascular invasion.
    Hou JZ; Zeng ZC; Zhang JY; Fan J; Zhou J; Zeng MS
    Int J Radiat Oncol Biol Phys; 2012 Oct; 84(2):362-8. PubMed ID: 22381903
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adverse hepatic events caused by radiotherapy for advanced hepatocellular carcinoma.
    Furuse J; Ishii H; Nagase M; Kawashima M; Ogino T; Yoshino M
    J Gastroenterol Hepatol; 2005 Oct; 20(10):1512-8. PubMed ID: 16174067
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multi-Institutional Phase II Study of High-Dose Hypofractionated Proton Beam Therapy in Patients With Localized, Unresectable Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma.
    Hong TS; Wo JY; Yeap BY; Ben-Josef E; McDonnell EI; Blaszkowsky LS; Kwak EL; Allen JN; Clark JW; Goyal L; Murphy JE; Javle MM; Wolfgang JA; Drapek LC; Arellano RS; Mamon HJ; Mullen JT; Yoon SS; Tanabe KK; Ferrone CR; Ryan DP; DeLaney TF; Crane CH; Zhu AX
    J Clin Oncol; 2016 Feb; 34(5):460-8. PubMed ID: 26668346
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.